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Aim: Lung function tests are essential for the diagnosis and management of bronchial asthma.
Impulse oscillation (IOS) system is an alternative way to measure lung mechanics for some pa-
tients. We investigated the relative sensitivities of IOS, body plethysmography and spirometry
in detecting allergen- and methacholine-induced bronchoconstriction.
Method: Twenty-two subjects had single allergen inhalation and 8 subjects had 3 methacholine
challenges. The tests were stopped when FEV1 fell by 20%. Lung function was measured using
IOS (R5, R20, R5-R20, X5, AX, fres), plethysmography (sRaw, sGaw, FRC, lung volumes) and
spirometry (FEV1, FVC, PEF, FEF50%) during inhalation challenges, and expressed as percent
change from pre-challenge baseline.
Results: All subjects were non-smoking adults with mild allergic asthma. Following allergen
challenges, the most sensitive IOS index was R5eR20 and the most sensitive plethysmography
and spirometry measurements were sRaw, sGaw and FEF50%. Following methacholine challenge
the most sensitive IOS index was AX, the most sensitive plethysmography measurement was
sRaw. Overall, IOS (R5eR20, AX, X5 Hz) proved to be more sensitive than plethysmography
and spirometry measurements following allergen-induced and methacholine-induced broncho-
constriction.
Conclusion: Our result shows that IOS is more sensitive than other lung function tests following
allergen and methacholine challenge. In addition, IOS can act as an alternative measurement
technique of airway resistance and obstruction in patients where manoeuvres involved in
plethysmography and spirometry prove difficult to perform.
ª 2013 Elsevier Ltd. All rights reserved.5) 525 9140x22791; fax: þ1 (905) 528 1807.
er.ca (G.M. Gauvreau).
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504 N. Naji et al.Introduction induced symptoms of dyspnoea, wheeze and chest tight-
ness, and closely associated with less dyspnoea scores inBronchial asthma is most commonly evaluated using spi-
rometric and plethysmographic measurements made at
baseline, following bronchodilators or during bronchial
provocation testing. For some patients such as children,
institutionalized and frail elderly patients and those with
difficulty performing forced respiratory manoeuvres,
alternative tests have been suggested.1e3
There is a poor correlation between asthma, degree
of airflow obstruction and FEV1,
4,5 which is partly related
to airway hyper-responsiveness (AHR), hyperinflation and
fluctuation of FEV1. This suggests the need for a more
sensitive test, such as impulse oscillometry, which may be
used for better evaluation of lung mechanics particularly
during methacholine-induced AHR.2,6e10
The forced oscillation technique (FOT) was introduced
by Dubois and colleagues over 50 years ago as an alternative
way to measure the mechanics of the respiratory system to
the traditional simultaneous measurements of pressure,
flow and volume at normal breathing frequencies.11
The Jaeger impulse oscillation system (IOS, Erich
Jaeger, Hoechberg, Germany) was introduced as a user-
friendly commercial version of the FOT. The utility of
IOS arises because it is simple, rapid, non invasive, does
not require forced manoeuvres that could influence
bronchial tone, and does not require confined spaces.12,13
IOS measures pulmonary impedance (Xrs) over a range of
frequencies (5e35 Hz). Lower frequencies (5 Hz) have
a slower cycle time and shorter wavelength, and reach the
periphery of the lungs. Pulmonary resistance (R) and
reactance (X), which is a composite index for airway elas-
ticity and inertia can be measured at lower frequencies (R5
and X5 Hz) to give information about the entire airway.
Frequencies propagate from central to peripheral airways,
therefore, R5 and X5 increase when there is central or
peripheral airway obstruction. Higher frequencies (20 Hz)
have a faster cycle time and longer wavelength. These
signals only penetrate and give information about the
proximal and larger airways, therefore increasing resist-
ance at R20 principally indicates central airflow obstruc-
tion. Disease confined to distal airways, however, will
increase resistance at the R5 more than at the R20, as the
latter constitutes only a small percentage of the total
resistance. This is measured as a differential change
(R5eR20). The area under curve of reactance (AX) between
5 Hz and resonant frequency (fres) represents a composite
index for reactance.
Previous studies showed that IOS measurements are
reproducible and provide sensitive indices compared to
FEV1.
1,14e16 It has been shown to be very sensitive in
assessment of airway hyper-responsiveness, airflow
obstruction, bronchodilator reversibility, in patients with
asthma and COPD.17,18 Vink and coworkers demonstrated
that the sensitivity of R and X to airway obstruction was
best at 5e15 Hz, and the rise in resistance preceded
the fall in FEV1, suggesting an increased sensitivity of IOS.
1
This may provide a significantly lower threshold value for
AHR, making methacholine challenge safer and faster.
Other studies have supported these findings.19 IOS has
also been shown to correlate well with methacholine-asthmatics.14,15
While a few studies in the past have compared forced
oscillation technique with that of spirometry in subjects
with asthma following allergen-induced bronchoconstri
ction20e22 there have been no studies comparing the rel-
ative sensitivities of IOS, plethysmography and spirometry
in adult asthmatic subjects following allergen-induced
bronchoconstriction. We investigated the relative sensi-
tivities of IOS (R5Hz, R20Hz, R5eR20, X5Hz, AX) to that
of body plethysmography (sRaw, sGaw, FRC) and spi-
rometry (FEV1, PEF, FEF50%) in detecting bronchocon-
striction following allergen inhalation and methacholine
challenge.Methods
Subjects
Twenty-two subjects were recruited for single allergen
inhalation challenges and 8 subjects were recruited for
methacholine challenges. The study was approved by the
institutional Research Ethics Board, and all subjects pro-
vided signed informed consent. Subjects were non-smoking
adults with mild allergic asthma as defined by methacholine
PC2016 mg/ml and FEV1 70% predicted during a screen-
ing visit, and infrequent (<twice weekly) use of short-
acting b2-agonists. Subjects were excluded if they had
lower respiratory tract infection, asthma exacerbation
within 4 weeks or used inhaled or oral steroids within 4
weeks. Short-acting b2-agonists were withheld 8 h before
all visits and antihistamines were withheld 72 h before
allergen challenges. Subject characteristics are shown in
Tables 1 and 2.
Study design
This observational study was conducted to determine the
relative sensitivity of IOS, plethysmography and spirometry
in detecting allergen- and methacholine-induced bron-
choconstriction. Following each inhalation period, mea-
surements of IOS, plethysmography and spirometry were
obtained, in this order, to avoid the effect of forced ma-
noeuvres of plethysmography and spirometry on bronchial
tone during IOS.
Impulse oscillometry
The impedance of the total respiratory system was meas-
ured using a MasterLab IOS system (Erich Jaeger Co,
Wurtzburg, Germany). During tidal breathing for 30 s, an
impulse generator produced brief pressure pulses (150 im-
pulses) at intervals of 0.2 s and the pressure fluctuations
were measured at the mouth. Subjects sat upright with,
nose clip in place and hands supporting the cheeks. Mean
resistance (R5, R20, R5eR20) Hz and reactance at 5 Hz (X5),
reactance area (AX) and resonant frequency (fres) were
calculated.
Table 1 Demographic details of the subjects undergoing allergen challenges.
Subject Sex Age
(years)
Height
(cm)
Weight
(kg)
Baseline
FEV1 (%pred)
Baseline
methacholine
PC20 (mg/ml)
Allergen
inhaled
EAR
(FEV1%fall)
LAR
(FEV1%fall)
1 F 20 160 64 109 16.00 HDM 43 5
2 M 20 181 68 97 2.40 HDM 31 0
3 F 22 170 60 93 2.25 Cat 24 1
4 F 19 172 60 97 0.62 HDM 55 7
5 M 45 186 102 96 5.48 HDM 22 11
6 M 20 175 82 123 2.54 HDM 22 6
7 M 42 175 80 73 0.29 Cat 38 18
8 F 18 164 65 76 1.06 Cat 23 10
9 F 22 163 55 75 0.39 Cat 24 6
10 M 24 183 73 85 6.18 Cat 21 1
11 F 20 160 51 84 19.35 HDM 42 31
12 F 23 178 86 80 0.62 HDM 19 9
13 F 25 171 75 109 6.57 HDM 26 5
14 F 20 166 54 96 2.34 Ragweed 25 3
15 F 27 167 68 93 6.52 HDM 15 15
16 F 20 158 61 99 7.32 Cat 23 2
17 M 21 176 72 74 0.77 Ragweed 46 29
18 F 19 156 60 100 2.89 CAT 20 11
19 M 20 172 63 90 2.25 HDM 21 2
20 M 19 178 68 78 4.89 HDM 36 42
21 F 23 172 65 67 15.49 HDM 29 50
22 M 59 180 76 93 1.50 CAT 38 7
Mean SD 13 F, 9 M 25 10 171 8 68 12 90 14 2.69 (0.29e19.35) 29 10 12 13
Comparison of changes in lung function 505Body plethysmography
Measurements weremade using a Vmax SensorMedics 6200
Autobox DL. Total lung capacity (TLC), residual volume (RV),
vital capacity (VC), inspiratory capacity (IC) and expiratory
reserve volume (ERV) were measured by tidal breathing, and
airway resistance (Raw), specific airway resistance (sRaw),
conductance (Gaw), specific airway conductance (sGaw),
functional residual capacity (FRC) and thoracic gas volume
(Tgv) weremeasured while panting at 1 cycle per second with
the airway occluded and unoccluded.
Spirometry
Spirometry was carried out using a Vmax SensorMedics
6200 Autobox DL. The FEV1, FVC, peak expiratory flow (PEF),
forced expiratory flow (FEF50%) and (FEF75%) were measured
and recorded. NHANES III predicted equations were utilized.Table 2 Demographic details of the subjects undergoing metha
Sex (M/F) Age (years) Height (cm) Weight (
M 59 180 76
F 21 180 79
F 19 170 67
F 19 155 54
M 18 178 67
M 20 172 62
F 22 164 63
M 22 180 68
4 F/4 M 25 13.9 172 9.1 67 7.9Part A e allergen challenge
Subjects recruited for the allergen challengeswere skin prick
tested to identify a suitable aeroallergen, and methacholine
PC20 was repeated at baseline on the day before allergen
challenge in order to calculate the allergen dose for inhala-
tion.23 Allergen challenges were carried out by 2 min of tidal
breathing doubling concentrations of allergen extract
through a Hans Rudolph valve connected to a Wright nebu-
lizer. Lung function was measured by IOS, plethysmography
and spirometry, in this order, at baseline and 10 min after
each dose of allergen. The challenge was stopped when the
FEV1 fell by 20% from the pre-allergen baseline.
24 Lung
function was then measured by IOS, plethysmography and
spirometry at 20, 30, 45, 60 and 90 min, then hourly up to 7 h
post-allergen challenge. The early asthmatic response (EAR)
was measured for up to 3 h post-allergen and the late phase
response (LAR) was measured between 3 and 7 h post-choline challenges.
kg) FEV1%predicted Methacholine PC20(mg/ml)
96 1.50
70 5.60
93 1.06
106 2.89
77 4.89
87 12.03
94 15.49
85 8.81
88 11.3 4.62 (1.06e15.49)
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Figure 1 Mean (95% confidence intervals) relative sensi-
tivities of spirometry measurements until 7 h following allergen
challenge expressed as a fold change from baseline.
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Figure 2 Mean (95% confidence intervals) relative sensi-
tivities of plethysmography measurements until 7 h following
allergen challenge expressed as a fold change from baseline.
506 N. Naji et al.allergen. The maximum percent fall in FEV1 was calculated
for the EAR and LAR (Table 1).
Part B e methacholine challenge
Subjects attended a screening visit for a medical assessment
and screening methacholine challenge to determine the
presence and severity of airway hyperesponsiveness (PC20).
At the next visit subjects had pulmonary function measured
by IOS, plethysmography and spirometry (in this order), at
baseline and again after each concentration of provocholine.
Methacholine challenges were carried out by 2 min tidal
breathing of doubling concentrations of provocholine
through a Hans Rudolph valve connected to a Wright nebu-
lizer. IOS was performed 30e60 s post-inhalation, ple-
thysmography was performed 1.5e2 min post-inhalation,
and spirometry was performed approximately 2 min post-
inhalation. Each inhalation of methacholine was separated
by 5 min. The test was terminated when the FEV1 fell by 20%.
Analysis of results
Following increasing doses of methacholine or allergen,
resistance progressively increased and flow rate progres-
sively decreased. Summary statistics are presented as
mean standard deviation, unless otherwise noted. The
relative sensitivity of the change in lung function post-
challenge was measured in an ordinal fashion. All values
were transformed and expressed as a fraction of the value at
baseline to allow comparison, the ordinate then was
expressed on a log scale such that a 50% reduction in flow
rate from control (0.5) is equivalent to a doubling of resist-
ance from control (2.0). The ordinates were then plotted
against time (for allergen challenges) or % change in FEV1
(for methacholine challenges). Sensitivity was defined by the
number of units above or below baseline and sensitivities
were rank ordered.
Results
Part A: allergen challenge
Twenty-two subjects inhaled an allergen to which they
were sensitized and the mean maximum % fall in FEV1
during the early response was 29 10%; 20 subjects had
a maximum % fall in FEV1 during the early response of 20%
from baseline and in two subjects the maximum % fall in
FEV1 during the early response was between 15% and 20%.
Six subjects developed a late asthmatic response, as
defined by a maximum % fall in FEV1 of 15% between 3 and
7 h post-challenge. The mean maximum % fall in FEV1 be-
tween 3 and 7 h post-allergen was 12 13% (Table 1).
The relative sensitivity of spirometry measurements is
shown in Fig. 1. The FEF50% was the most sensitive spiro-
metric measurement recorded during both the early and
late asthmatic responses, with relative sensitivity reaching
0.57 0.14 and 0.81 0.13, respectively, which was similar
to the FEF25e75% (Fig. 1) and FEF75% (data not shown).
Forced expiratory mid-flow rates were more sensitive than
the FEV1, which had a relative sensitivity reaching only0.74 0.11 and 0.87 0.16 during the early and late re-
sponses, respectively. The PEF had a similar sensitivity to
the FEV1, and the FVC was considerably less sensitive with
sensitivity values close to 1 (Fig. 1).
Measurements of plethysmography demonstrate that
sRaw and sGaw are more sensitive than RV, FRC and TLC
(Fig. 2), VC, IC, Raw, Gaw and Vtg (data not shown) to
detect allergen-induced changes in lung function during the
early and late asthmatic responses. Furthermore, sRaw and
sGaw have higher sensitivity values (farther from a value of
1) than the mid-flow rates measured by spirometry.
The relative sensitivities of IOS measurements following
allergen challenge are shown in Fig. 3. Measurements of R5-
R20 and AX have the highest sensitivity of all other mea-
surements, being 2e3 times higher than sRaw and sGaw.
The least sensitive IOS measurements were R5Hz, R20Hz,
X5Hz, X20Hz, Z5Hz, and fres (data not shown).
Part B: methacholine challenge
Eight subjects had methacholine challenges. The mean
FEV1% at baseline was 88 11.3%, and the mean provocative
concentration of methacholine causing 20% fall in FEV1
(PC20) was 4.62 mg/ml. 3 subjects had PC20< 4 mg/ml, 2
subjects had PC20 between 4 and 8 mg/ml and 3 subjects
had PC20 between 8 and 16 mg/ml (Table 2). The relative
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Figure 3 Mean (95% confidence intervals) relative sensi-
tivities of IOS measurements until 7 h following allergen chal-
lenge expressed as a fold change from baseline.
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Figure 5 Mean (95% confidence intervals) relative sensi-
tivities of plethysmography measurements expressed as a fold
change from baseline and plotted against % fall in FEV1 during
methacholine-induced bronchoconstriction.
Comparison of changes in lung function 507sensitivities of spirometry measurements during methacho-
line challenge are shown in Fig. 4. FEF50% and FEF25e75% were
the most sensitive spirometry measurements compared to %
fall in FEV1, with relative sensitivity reaching 0.56 0.09
and 0.57 0.04, respectively, the sensitivity of PEF was
similar to FEV1. The least sensitive measurement was FVC
which was close to 1 (0.87 0.04). Measurements of ple-
thysmography also demonstrate that sRaw and sGaw are
more sensitive than RV, FRC and TLC (Fig. 5), VC, IC, Raw,
Gaw and Vtg (data not shown) to detect methacholine-
induced bronchoconstriction and that sRaw and sGaw have
higher sensitivity values (farther from a value of 1) than the
mid-flow rates measured by spirometry.
The relative sensitivities of IOS measurements following
methacholine challenge are shown in Fig. 6. Measurements
of AX and R5-R20 Hz have the highest sensitivity of all other
measurements, being 3e4 times higher than sRaw and sGaw.
The least sensitive IOS measurements were R5 Hz, R20 Hz,
fres and X5Hz (data not shown). Baseline values for spi-
rometry, plethysmography and IOS for subjects undergoing
allergen and methacholine challenges are shown in Table 3.
Discussion
The purpose of this study was to investigate the relative
sensitivities of IOS, body plethysmography and spirometry
in detecting bronchoconstriction following allergen and0.1
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Figure 4 Mean (95% confidence intervals) relative sensi-
tivities of spirometry measurements expressed as a fold change
from baseline and plotted against % fall in FEV1 during
methacholine-induced bronchoconstriction.methacholine challenges. Twenty-two atopic asthmatics
underwent allergen challenge and were then assessed with
pulmonary function testing (IOS, body plethysmography and
spirometry); measurements were then compared during EAR
and LAR. Eight asthmatics underwent 3 methacholine chal-
lenges with similar lung function tests measured after each
dose. R5-R20 and AX were the most sensitive indices of
bronchoconstriction and R20Hz was the least sensitive index.
For plethysmography and spirometry; sRaw followed by
sGaw and then FEF50% were the most sensitive measure-
ments compared to FEV1. Overall, IOS measurements proved
to be more sensitive measures of bronchoconstriction than
those of both plethysmography and spirometry.
Current ATS criteria rely on measuring FEV1 to diagnose
asthma. However, there are many drawbacks to this. Many
patients have normal spirometry at the time of assessment
require methacholine challenge to make the diagnosis.
Therefore, ATS criteria are not suitable for many asthma
patients whose FEV1 values are close to normal.
25e27 Also,
spirometry and body plethysmography require active patient
cooperation and may, therefore be difficult for some pa-
tients to perform.1e3 In addition, performing forced ma-
noeuvres to measure the FEV1 influences bronchial tone. IOS
was introduced as an alternative way to measure the me-
chanics of the respiratory system. Previous studies have
demonstrated an increased sensitivity of IOS compared to0.01
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Figure 6 Mean (95% confidence intervals) relative sensitiv-
ities of IOS measurements expressed as a fold change from
baseline and plotted against % fall in FEV1 during methacholine-
induced bronchoconstriction.
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508 N. Naji et al.spirometry,1,14,15,17 and compared to spirometry and ple-
thysmography following bronchodilator administration in
stable asthmatics.28 Our results are consistent with these
studies: we found IOS measurements to be more sensitive
than spirometry and body plethysmography measurements in
detecting both allergen- and methacholine-induced bron-
choconstriction. The increased sensitivity of IOS holds
promise for its use in bronchoprovocation tests, where it can
decrease the duration of test times and doses required to
induce bronchoconstriction, thereby making the tests faster
and “safer” for patients. Until the reliability of IOS as well as
standardized guidelines of its usage can be better estab-
lished, IOS should not be interchangeable with that of ple-
thysmography or spirometry. However, IOS can act as an
alternative measurement technique of airway resistance and
obstruction for certain categories of patients, where ma-
noeuvres involved in plethysmography and spirometry prove
difficult to perform.
Investigation of the role of small airways in asthma has
previously lagged because of the difficulty in assessing this
area. We have since come a long way, as with the help of
newer techniques, airway inflammation, remodelling and
functional changes have all been well documented in the
small airways.29e31 Our study found the most sensitive
measurements of bronchoconstriction to be R5eR20, AX,
sRaw, sGaw and FEF50%, which have been shown to reflect
small airway obstruction with regional inhomogeneity, while
sRaw and sGaw also reflect airway resistant and conducance
from larger airways.32 Others have shown that sRaw can
differentiate between healthy and asthmatics, and that it is
more specific than Raw in asthmatic children.33 Plethysmo-
graph and spirometry assessments during bronchial inhala-
tion challenges show that up to 20% of subjects demonstrate
a positive response in sRaw without sufficient response in
FEV1.
34 Likewise, the provocative concentration of histamine
causing a 40% fall in sGaw was more sensitive than PC20 FEV1
in detecting bronchoconstriction,35 and adding measurement
of sGaw to FEV1 was shown to increase the sensitivity of
methacholine challenges.36 Therefore it is not surprising to
observe that sRaw and its reciprocal value, aGaw, are more
sensitive than FEV1 to allergen- and methacholine-induced
bronchoconstriction.
During airflow obstruction, the pulmonary resistance at
the low frequency of 5 Hz is much higher than that of the
higher frequency at 20 Hz, and this reflected by an increased
resistance at R5e20 Hz.37,38 Our results are consistent with
other studies suggesting that R5eR20 Hz and AX reflect small
airway resistance and are closely related to methacholine-
induced bronchoconstriction.
R5eR20 Hz and AX were more sensitive than R5 Hz,
which correlated poorly with changes in FEV1, and there
was no change in R20 Hz reflecting no change in proximal
airway obstruction.39 These observations suggest that
methacholine-induced symptoms are associated with distal
airway hetrogeniety, and are supported by other studies
showing a higher sensitivity of R5-R20 and AX in monitoring
bronchoconstriction and responses to therapy.40,41 We
demonstrated that R5 Hz was the least sensitive index
compared to FEV1. In contrast, the PC40-Rrs 6 Hz measured
by forced oscillation in an earlier report was found to
shorten the duration of methacholine challenge and allow
lower doses of methacholine to be delivered compared to
Comparison of changes in lung function 509PC20 FEV1.
14 Methodological differences could contribute
to this apparent difference, including generation of larger
particles by the DeVilbiss nebulizer with preferential dep-
osition in the larger or medium-sized airway, thus increas-
ing resistance at Rrs 6 Hz.
In addition, R20Hz, a proposed measure of large airway
obstruction,42 was the least sensitive index in the current
study. This was not surprising, as previous studies showed
that patients with airflow obstruction could be identified
by most IOS parameters except for R20 Hz.43 These findings
collectively suggest that peripheral airways may play a sig-
nificant role in methacholine-induced bronchoconstriction,
andduringEARandLAR inallergen-inducedasthma.TheLAR,
thought to result from the infiltration of inflammatory cells
and its consequences (ex. mucus secretion and oedema) into
the airways, has been suggested to preferentially occur in
the small airways.44 Also, Zeidler et al. demonstrated wor-
sening small airway obstruction (as indicated by lower lung
attenuationmeasured by high resolution CTand an increased
closing volume) in atopic asthmatics at 6 and 23 h after
exposure to natural cat allergen, corresponding to the LAR
and possibly resulting from small airway inflammation.45 Our
results are consistent with these studies. The EAR, however,
results primarily from the cellular release of histamine and
lipid mediators and their subsequent binding receptors on
airway smooth muscle. Histamine-responsive receptors
mainly reside in the large airways 46 however,weobserved no
changes in R5 Hz or R20 Hz. In contrast, we observed an
increase in resistance at R5eR20 Hz during EAR, which may
reflect the effects of cysteinyl leukotrienes binding to re-
ceptors in the small airways.47 More investigation into the
roles of large versus small airways in allergen-induced
asthma is required.
Our findings of increasing resistance in the smaller airways
during bronchoprovocationwithmethacholine and allergen is
consistent with previous work, and IOS measurements have
shown to be consistently more sensitive than those of ple-
thysmography and spirometry. Clinically, IOS could be
implemented in patients unable to perform spirometry, and
may reduce the time and dose of challenge agent, thereby
making the procedure safer. However, IOS should not be
interchangeable with that of plethysmography or spirometry
until the reliability, correlation to clinical disease anddisease
severity, and standardized guidelines for IOS are established.
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